Neuroprotective effect of gypenosides against oxidative injury in the substantia nigra of a mouse model of parkinson's disease

Journal of International Medical Research

Volumn 38, Issue 3, 2010, Pages 1084-1092

  Wang, P ^a   Niu, L ^a   Gao, L ^a   Li, W X ^a   Jia, D ^a   Wang, X L ^a   Gao, G D ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Dopamine; Glutathione; Gypenosides; Oxidative stress; Parkinson's disease; Superoxide dismutase

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; DOPAMINE; GLUTATHIONE; GYPENOSIDE; SUPEROXIDE DISMUTASE; ANTIOXIDANT; NEUROPROTECTIVE AGENT; PLANT EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DOPAMINE BLOOD LEVEL; DOPAMINERGIC NERVE CELL; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; MALE; MOTOR DYSFUNCTION; MOUSE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; SUBSTANTIA NIGRA; ANIMAL; ANIMAL BEHAVIOR; BRAIN; BRAIN LEVEL; DISEASE MODEL; DNA DAMAGE; DRUG EFFECTS; GYNOSTEMMA; LIPID PEROXIDATION; METABOLISM; MOTOR PERFORMANCE; PARKINSONIAN DISORDERS; PATHOLOGY; PATHOPHYSIOLOGY; PROTEIN CARBONYLATION; ROTAROD TEST;

ANIMALS; ANTIOXIDANTS; BEHAVIOR, ANIMAL; BRAIN; BRAIN CHEMISTRY; DISEASE MODELS, ANIMAL; DNA DAMAGE; DOPAMINE; GLUTATHIONE; GYNOSTEMMA; LIPID PEROXIDATION; MICE; MOTOR SKILLS; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; PARKINSONIAN DISORDERS; PLANT EXTRACTS; PROTEIN CARBONYLATION; ROTAROD PERFORMANCE TEST; SUBSTANTIA NIGRA; SUPEROXIDE DISMUTASE;

EID: 77954794983     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001003800336     Document Type: Article

References (30)

1. Dauer W, Przedborski S: Parkinson's disease: mechanisms and models. Neuron 2003;39: 889-909.
2. Fahn S, Cohen G: The oxidant stress hypothesis in Parkinson's disease: evidence supporting it. Ann Neurol 1992; 32: 804-812.
3. Adams JD Jr, Chang ML, Klaidman L: Parkinson's disease: redox mechanisms. Curr Med Chem 2001; 8: 809-814.
4. Sofic E, Lange KW, Jellinger K, et al: Reduced and oxidised glutathione in the substantia nigra of patients with Parkinson's disease. Neurosci Lett 1992; 142: 128-130.
5. Sian J, Dexter DT, Lees AJ, et al: Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann Neurol 1994; 36: 348-355.
6. Saravanan KS, Sindhu KM, Mohanakumar KP: Melatonin protects against rotenone-induced oxidative stress in a hemiparkinsonian rat model. J Pineal Res 2007; 42: 247-253.
7. Verma R, Nehru B: Effect of centrophenoxine against rotenone-induced oxidative stress in an animal model of Parkinson's disease. Neurochem Int 2009; 55: 369-375.
8. Dexter DT, Holley AE, Flitter WD, et al: Increased levels of hydroperoxides in the parkinsonian substantia nigra - an HPLC and ESR study. Mov Disord 1994; 9: 92-97.
9. Yoritaka A, Hattori N, Uchida K, et al: Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proc Natl Acad Sci USA 1996; 93: 2696-2701.
10. Alam ZI, Daniel SE, Lees AJ, et al: A generalized increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease. J Neurochem 1997; 69: 1326-1329.
11. Alam ZI, Jenner A, Daniel SE, et al: Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine in substantia nigra. J Neurochem 1997; 69: 1196-1203.
12. Chen JC, Tsai CC, Chen LD, et al: Therapeutic effect of gypenoside on chronic liver injury and fibrosis induced by CCl4 in rats. Am J Chin Med 2000; 28: 175-185.
13. La Cour B, Molgaard P, Yi Z: Traditional Chinese medicine in treatment of hyperlipidaemia. J Ethnopharmacol 1995; 46: 125-129.
14. Megalli S, Aktan F, Davies NM, et al: Phytopreventative anti-hyperlipidemic effects of Gynostemma pentaphyllum in rats. J Pharm Pharm Sci 2005; 8: 507-515.
15. Wang QF, Chen JC, Hsieh SJ, et al: Regulation of Bcl-2 family molecules and activation of caspase cascade involved in gypenosides induced apoptosis in human hepatoma cells. Cancer Lett 2002; 183: 169-178.
16. Shang L, Liu J, Zhu Q, et al: Gypenosides protect primary cultures of rat cortical cells against oxidative neurotoxicity. Brain Res 2006; 1102: 163-174.
17. Ogawa N, Hirose Y, Ohara S, et al: A simple quantitative bradykinesia test in MPTP-treated mice. Res Commun Chem Pathol Pharmacol 1985; 50: 435-441.
18. Rozas G, Labandeira Garcia JL: Drug-free evaluation of rat models of parkinsonism and nigral grafts using a new automated rotarod test. Brain Res 1997; 749: 188-199.
19. Novikova L, Garris BL, Garris DR, et al: Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine probenecid model of Parkinson's disease. Neuroscience 2006; 140: 67-76.
20. Cass WA, Harned ME, Peters LE, et al: HIV-1 protein Tat potentiation of methamphetamine-induced decreases in evoked overflow of dopamine in the striatum of the rat. Brain Res 2003; 984: 133-142.
21. Smith MP, Cass WA: Oxidative stress and dopamine depletion in an intrastriatal 6-hydroxydopamine model of Parkinson's disease. Neuroscience 2007; 144: 1057-1066.
22. Tietze F: Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem 1969; 27: 502-522.
23. Kono Y: Generation of superoxide radical during auto-oxidation of hydroxylamine and an assay of superoxide dismutase. Arch Biochem Biophys 1978; 186: 189-195.
24. Poon HF, Joshi G, Sultana R, et al: Antisense directed at the Ap region of APP decreases brain oxidative markers in aged senescence accelerated mice. Brain Res 2004; 1018: 86-96.
25. Wills ED: Mechanism of lipid peroxide formation in animal tissue. Biochem J 1966; 99: 667-676.
26. Jenner P: Molecular mechanisms of L-DOPA-induced dyskinesia. Nat Rev Neurosci 2008; 9: 665-677.
27. Freed CR, Greene PE, Breeze RE, et al: Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med 2001; 344: 710-719.
28. Tainer JA, Getzoff ED, Richardson JS, et al: Structure and mechanism of copper, zinc superoxide dismutase. Nature 1983; 306: 284-287.
29. Dringen R: Metabolism and functions of glutathione in brain. Prog Neurobiol 2000; 62: 649-671.
30. Dringen R, Pawlowski PG, Hirrlinger J: Peroxide detoxification by brain cells. J Neurosci Res 2005; 79: 157-165.